source
- Alnylam cuts Amvuttra sales guidance as demand shifts, hurting stockAlnylam’s second-quarter earnings report Thursday did little to assuage investor concerns in what has already been a difficult year for the company. The drugmaker lowered its full-year sales projec…Endpoints · 5h ago↗ source
- STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuelsUnitaid found the rising price of oil could boost the cost of a widely used HIV medicine it reviewed in a detailed analysis.STAT · 5h ago↗ source
- Relation promises 'transformationally different success rates' in expanded AI pact with GSKGSK is set to pay Relation Therapeutics up to $110 million to expand their existing partnership to use AI modeling for drug discovery. Under the Thursday deal, Relation will build a ...